DIGESTIVE ADVANTAGE IRRITABLE BOWEL SYNDROME OTC
Generic Name and Formulations:
GanedenBC30 (Bacillus coagulans GBI-30, 6086), lysine; vegetarian caps; lactose-free; may contain trace amounts of casein (milk protein).
Indications for DIGESTIVE ADVANTAGE IRRITABLE BOWEL SYNDROME:
For the daily dietary management of IBS symptoms.
Capsules may be opened and contents sprinkled into food or drink. 1 capsule daily. Max 2 caps/daily.
Capsules may be opened and contents mixed into cold drink, oatmeal, applesauce or other food. 1 capsule daily.
Antagonized by antibiotics.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|